← Back to Search

Behavioral Intervention

Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List for Ovarian Cancer (ASQ-GYO Trial)

N/A
Waitlist Available
Led By Ira Winer, MD PhD
Research Sponsored by Ira Winer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the patients in the intervention group will complete this within 1 week after their visit.
Awards & highlights

ASQ-GYO Trial Summary

This trial aims to see if using a set of questions called ASQ-GYO QPL can help new patients with gynecologic cancer feel more confident, less stressed, and trust their doctor more.

Who is the study for?
This trial is for new patients with various gynecologic cancers such as ovarian, cervical, endometrial, vulvar, and vaginal cancer. Participants should be those who are about to have their first oncology visit.Check my eligibility
What is being tested?
The study tests if a special list of questions called the ASQ-GYO Question Prompt List can help patients feel more confident, less distressed, trust their doctor more, and understand their condition better compared to standard care.See study design
What are the potential side effects?
Since this intervention involves asking questions rather than medical treatment or drugs, there are no direct physical side effects expected from participating in this trial.

ASQ-GYO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all participants will complete a post-visit knowledge screen once within 1 week after their visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and all participants will complete a post-visit knowledge screen once within 1 week after their visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pre- and post-visit self-efficacy scores and compared by trial group
Secondary outcome measures
Change in pre- and post-visit National Comprehensive Cancer Network (NCCN) Distress Thermometer scores compared by trial group
Change in pre- and post-visit Trust in a Physician scores compared by trial group
Knowledge Screen
+1 more

ASQ-GYO Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt ListExperimental Treatment1 Intervention
Participants are provided with a question prompt list
Group II: No administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt ListActive Control1 Intervention
Participants will not be provided with the question prompt list

Find a Location

Who is running the clinical trial?

Ira WinerLead Sponsor
1 Previous Clinical Trials
62 Total Patients Enrolled
Ira Winer, MD PhDPrincipal InvestigatorBarbara Ann Karmanos Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently open for enrollment?

"According to details on clinicaltrials.gov, recruitment for this specific trial is closed. The trial was initially listed on 4/1/2024 and last updated on 3/27/2024. Despite this trial no longer accepting applicants, there are currently 936 other trials actively seeking participants."

Answered by AI
~47 spots leftby Feb 2025